You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myelomonocytic, Chronic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Active, not recruiting
  • Chronic Myelomonocytic Leukemia-0
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2023

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

Not yet recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
Oct 20, 2022

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

    Active, not recruiting
    • Chronic Myelomonocytic Leukemia
    • Leukemia
    • Tampa, Florida
    • +4 more
    Nov 11, 2022

    Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen

    Recruiting
    • Recurrent Chronic Myelomonocytic Leukemia
    • Refractory Chronic Myelomonocytic Leukemia
    • Biospecimen Collection
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Chronic Myeloid Leukemia Trial in France (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Amiens, France
    • +14 more
    Mar 3, 2023

    Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

    Not yet recruiting
    • Higher Risk Myelodysplastic Syndrome
    • Chronic Myelomonocytic Leukemia
    • (no location specified)
    Jul 29, 2022

    Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • Chronic Myelomonocytic Leukemia
    • LILRB4 STAR-T cells injection
    • Tianjin, Tianjin, China
    • +1 more
    Feb 12, 2023

    Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

    Not yet recruiting
    • Immune System Diseases
    • +15 more
    • observational cohort study
    • (no location specified)
    Jul 23, 2023

    Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • +4 more
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    May 30, 2023

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • DSP107
    • +2 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center, Department of
    Nov 13, 2022

    Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

    Active, not recruiting
    • Myelofibrosis
    • Chronic Myelomonocytic Leukemia
    • Duarte, California
    • +9 more
    Jan 24, 2023

    MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

    Recruiting
    • Myelodysplastic Syndromes
    • Myeloproliferative Chronic Myelomonocytic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 31, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Los Angeles, California
    • +5 more
    Jan 27, 2023

    Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • +2 more
    • Duarte, California
    • +1 more
    Mar 14, 2023

    MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • unrelated umbilical cord blood
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Oct 16, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Aug 17, 2022